InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by Plooster Matthew R, Director. Insider active across 1 company, notably Kempharm, INC. Aggregated, 3 reports have been published. Split: 1 buy · 0 sell. Total volume traded: €3k. Activity tracked since 1 December 2021. The latest transaction was filed on 18 May 2022 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations3 total
695 shares@ US$4.948.1% of flowCommon StockSEC:0001437749-22-012945:0
Ideal exit: 12 Feb 2023 (T+270)
2,500 shares@ US$8.4446.0% of flowCommon StockSEC:0001437749-21-027630:0
2,500 shares@ US$8.44100.0% of flowCommon StockSEC:0001437749-21-027630
3 of 3 declarations
About Plooster Matthew R
Matthew R. Plooster is a Director at KEMPHARM, INC. In this role, he participates in the governance and strategy of the company. His experience is valuable for the development of KEMPHARM.
